 SEATTLE, Feb. 24, 2021 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Adaptive Biotechnologies Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2020. 